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Introduction. Adipose tissue contributes to atherosclerosis with mechanisms related to adipokine secretion. Polyphenols may
exhibit antiatherogenic properties. The aim of the study was to investigate the eﬀects of three polyphenols, namely, quercetin,
epigallocatechin gallate (EGCG), and resveratrol on adipokine secretion from cultured human adipocytes. Methods.H u m a nS G B S
adipocytesweretreatedwithquercetin,EGCG,andresveratrolfor24and48hours.Visfatin,leptin,andadiponectinweremeasured
in the supernatant. Results. Visfatin secretion was inhibited by quercetin 10μM by 16% and 24% at 24 and 48hours respectively.
The corresponding changes for quercetin 25μM were 47% and 48%. Resveratrol 25μM reduced visfatin by 28% and 38% at 24
and 48hours. EGCG did not have an eﬀect on visfatin. None of tested polyphenols inﬂuenced leptin and adiponectin secretion.
Conclusion. Quercetin and resveratrol signiﬁcantly decreased visfatin secretion from SGBS adipocytes. This eﬀect may contribute
to their overall antiatherogenic properties.
1.Introduction
Obesity, deﬁned as body mass index over 30kg/m2,h a s
emerged over the past thirty years as a major public health
issue. The extent of the problem is ever-growing with inci-
dence reaching epidemic dimensions, especially in Western
societies. Obesity increases the risk of developing insulin
resistance, diabetes mellitus, hypertension, and coronary
heart disease and overall is associated with elevated morbid-
ity and mortality [1]. Several explanations have been oﬀered
[2], yet one widely accepted is that adipose tissue serves
morethanmereneighboringorganinsulatorandtriglyceride
depot storage [3]. In fact, adipocytes produce and secrete
a variety or proteins, collectively termed adipokines that
exhibit important metabolic and inﬂammatory properties,
[3]. Of particular interest are adipokines leptin, adiponectin
and visfatin, each with unique properties.
Leptin, the primary adipokine, has a primary role in
appetite suppression and downregulation of food intake
[2, 3]. Thus, knock-out mice are massively obese. In humans
though only few cases have been described, while the
common form of obesity is presented with high leptin
levels, indicating a condition of leptin resistance. Insulin
resistance and diabetes are also associated with higher leptin
levels. Moreover, leptin has been found to exhibit a role
in lipoprotein and glucocorticoid metabolism, as well as
in immune function. Similarly to leptin, adiponectin is
mainly produced from adipose tissue, as the most abun-
dant adipokine [2, 3]. Adiponectin levels are decreased
in obesity, insulin resistance, and type 2 diabetes. It has
been proposed that low circulating adiponectin levels are
indicative of increased cardiovascular risk, since it exhibited
antiatherogenic, insulin-sensitizing, and anti-inﬂammatory
properties. Visfatin, initially identiﬁed as a growth factor
for early B-cells, is mainly produced by visceral fat [4, 5].
It exerts insulin-mimetic eﬀects in vivo and in vitro and is
upregulated in obesity, metabolic syndrome, and diabetes.
It is also implicated in dyslipidaemia, hypertension, and2 Biochemistry Research International
generally atherosclerotic-related diseases [4, 5]. We have
recently shown that subjects with metabolic abnormalities
that predispose to the development of cardiovascular disease
exhibit increased serum visfatin concentrations [4, 5]. How-
ever, the pathophysiologic signiﬁcance of this relationship
remains to be elucidated.
Combating obesity has been under scientiﬁc investi-
gation for many years, and several strategies are being
developed to manage this public health issue. Dietary mod-
ulation is considered ﬁrst-treatment option. Plant-derived
polyphenols, such as ﬂavonoids and resveratrol, as part of
humannutrition,havebeenputontest.Epidemiologicaland
clinical evidence suggests a protective role against cardiovas-
cular disease [6–8]. In addition, results from both animal
and clinical studies are promising regarding antiobesity
eﬀects [9–13]. In the present study, we aim to investigate
the direct eﬀect of ﬂavonoids quercetin, epigallocatechin
gallate (EGCG), and resveratrol on the secretion of leptin,
adiponectin, and visfatin from human adipocytes in culture.
2. Methods
Quercetin, EGCG, resveratrol, Dulbecco’s modiﬁed Eagle’s
medium (DMEM)/Ham’s F12, penicillin/streptomycin, bi-
otin, pantothenate, L-glutamine, isobutylmethylxanthine
(IBMX), dexamethasone, insulin, transferring triiodothyro-
nine (T3), were purchased from Sigma (St. Louis, USA),
fetal calf serum (FCS) from GIBCO (California, USA), and
rosiglitazone (BRL49653) from Cayman Chemicals (Mich,
USA). Simpson-Golabi-Behmel syndrome (SGBS) cells were
maintained and diﬀerentiated into adipocytes as previously
described [14]. In brief, cells were cultured in 24-well plates
in DMEM/Ham’s F12 supplemented with 10% FCS, peni-
cillin/streptomycin, L-glutamine, 33μM biotin, and 17μM
pantothenic acid and incubated at 37◦C in a humidiﬁed
atmosphere of 5% CO2.C e l l sw e r eg r o w nt oc o n ﬂ u e n c e
for 5 days. Subsequently, we initiated the adipocyte dif-
ferentiation program. Medium was changed into serum-
free DMEM/F12, containing penicillin/streptomycin, biotin,
pantothenic acid, 0.01mg/mL transferrin, 0.1μM cortisol,
200pM T3, 20nM human insulin, 0.25μM dexametha-
sone, 500μM IBMX, and 2μM rosiglitazone (diﬀerentiation
medium). On day 4, medium was replaced by the diﬀerenti-
ation medium lacking rosiglitazone, IBMX, and dexametha-
sone (medium 2) and cells were cultured for additional 11
days in medium 2, which was changed every 3 days [14].
The cell diﬀerentiation into adipocytes was conﬁrmed
by (1) microscopic observation with simultaneous oil red
O staining (0.5% oil red O) [15]; (2) determination of the
triglyceride (TG) content in the cell lysate with the GPO
Trinder method [16]. To prepare the cell-lysate, adipocytes
were washed 3 times with phosphate-buﬀered saline (PBS,
pH 7.4) and then were lysed with 200μLo fl y s i sb u ﬀer
containing 0.1% Triton X in PBS. Cell lysate was further
homogenizedbysonication.Theproteincontentofcelllysate
was determined by the Lowry method [17].
The eﬀect of polyphenols on adipokine secretion was
studied on fully diﬀerentiated adipocytes, that is, at 15 days
[14]. Three independent experiments were performed in
duplicate: SGBS adipocytes were rinsed twice with PBS and
then treated for 24 and 48 hours with medium 2, containing
additionally quercetin, EGCG, or resveratrol. All polyphe-
nols were dissolved in dimethyl sulfoxide (DMSO). The
maximum DMSO concentration into the culture medium
did not exceed 0.2% by volume. Secreted adipokines were
determined in duplicate in the cell supernatant collected
from each well. Leptin and adiponectin were measured
using kits purchased from BioVendor (Czech Republic) and
visfatin with a kit from Alpco (Salem, USA) according
to manufacturer’s protocol. Coeﬃcient of variation for
within and between kits was less than 7% for all three
kits. Each concentration obtained was determined from
the standard curve and after adjustment for protein lysate
content of respective well. Results are reported as means
with the standard error of the mean. Statistical analysis
was performed using SPPS statistical package for Windows
(SPSS Inc., Chicago, Ill, USA). Distribution was evaluated
by Kolmogorov-Smirnov test, and comparisons of only two
groupmeanswereperformedbyStudent’st-test.Signiﬁcance
was set at P ≤ 0.05.
3. Results
We obtained fully diﬀerentiated mature adipocytes, 15 days
after diﬀerentiation program induction, in accordance with
previously published results [14]. Adipocyte diﬀerentiation
was conﬁrmed by microscopic observation of cells stained
with oil red O (data not shown) and by quantitation
of the cell TG content, expressed per μg of cell protein.
Before the initiation of the diﬀerentiation program, the TG
concentration was lower than the detection limit of the
methodusedinthepresentstudy(i.e.,lowerthan16μg/mL);
however, 15-days diﬀerentiated mature adipocytes contained
detectable amounts of TG having a TG to cell protein ratio
of 1.14 ± 0.14μg/μg (no diﬀerence was observed between
various wells). Mature adipocytes secrete in the supernatant
all three adipokines evaluated in the present study, 24 hours
after changing the medium 2, whereas none of them was
detected in the supernatant from cultured undiﬀerentiated
ﬁbroblasts at day 4 (data not shown), thus further indicating
functionality of adipocytes (leptin 98 ± 22ng/mg cell pro-
tein, adiponectin 81 ± 23ng/mg cell protein, visfatin 320 ±
70ng/mg cell protein).
The eﬀect of polyphenols used in the present study on
adipokinesecretionwasstudiedasdescribedinMaterialsand
Methods. In preliminary experiments, we used polyphenol
concentrations ranging from 10 to 50μM. However, at
concentrationshigherthan40μM,aprecipitatewasobserved
in the cell supernatant for all polyphenols, immediately after
the substance addition. Hence, we evaluated their eﬀect on
adipokines’ secretion at lower concentrations, that is, at 10
and 25μM. None of the three polyphenols tested inﬂuenced
cellTG/proteinratioandleptinoradiponectinconcentration
in the cell supernatant at 24 hours and 48 hours (Figure 1).
Similarly, EGCG had no eﬀect on visfatin secretion at both
time points. By contrast, incubation of adipocytes with
quercetin resulted in a signiﬁcant dose-dependent reduction
of visfatin secretion (Figure 2). More speciﬁcally, quercetinBiochemistry Research International 3
0
20
40
60
80
100
120
140
160
Control Quercetin EGCG Resveratrol
L
e
p
t
i
n
(
n
g
/
m
g
c
e
l
l
p
r
o
t
e
i
n
)
(a)
0
20
40
60
80
100
120
140
Control Quercetin EGCG Resveratrol
A
d
i
p
o
n
e
c
t
i
n
(
n
g
/
m
g
c
e
l
l
p
r
o
t
e
i
n
)
10µM, 24hours
25µM, 24hours
10µM, 48hours
25µM, 48hours
Control, 24hours
Control, 48hours
(b)
Figure 1: Polyphenols quercetin, epigallocatechin gallate (EGCG),
andresveratroldonotaﬀectleptin(a)andadiponectin(b)secretion
by human mature SGBS adipocytes. Cells were cultured in medium
and incubated with 10 or 25μM of quercetin, EGCG, and resvera-
trol for 24 and 48 hours. Leptin and adiponectin were determined
in the cell supernatant by commercially available methods. Values
represent the mean ± SD.
10μM reduced visfatin secretion by 16% and 25% at 24 and
48 hours, respectively (P<0.05 versus control), whereas the
corresponding changes for quercetin 25μM were 47% and
48% (P<0.05 versus control and P<0.05 versus 10μM
in the same time points). Low concentration of resveratrol
had no eﬀect on visfatin secretion, while the 25μM of the
substance decreased visfatin concentration by 28% and 38%
at 24 and 48 hours, respectively, (P<0.05 versus control
for both comparisons). These changes were similar to those
observed with the high dose of quercetin.
In order to evaluate whether the decrease in the visfatin
concentration in the cell supernatant of cells treated with
quercetin or resveratrol is due to the reduction in visfatin
production, we determined the quercetin and resveratrol
eﬀects on both the cell-associated and the secreted visfatin
levels. We measured intracellular and secreted visfatin levels
in the presence of both polyphenols at both concentrations
tested. Measuring intracellular visfatin in cell lysate yielded
minimal amounts, in the order of hundredth relative to
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Figure 2: Eﬀect of polyphenols quercetin, epigallocatechin gallate
(EGCG), and resveratrol on visfatin secretion by human mature
SGBS adipocytes at 24 and 48 hours. Cells were cultured in
medium and incubated with 10 or 25mM of quercetin, EGCG, and
resveratrol for 24 and 48 hours. Visfatin levels were determined
in the cell supernatant by commercially available methods. Values
represent the mean ± SD. ∗P<0.05 compared with corresponding
control,
§P<0.05 compared with the value obtained at 10μM.
the total visfatin in the supernatant and without diﬀerence
between wells (4.1 ± 0.9ng visfatin/mg cell protein, p = NS
between wells), suggesting that (1) in SGBS adipocytes, vis-
fatin is a secretory protein and (2) quercetin and resveratrol
reduced its production.
4. Discussion
Obesity is now considered a low-grade inﬂammatory state.
Thus, it is supported that its management should not solely
be targeted to weight loss, but also towards correction of
metabolic imbalance of adipokines. In the present study, we
aimed to investigate possible eﬀect of three speciﬁc plant
polyphenols on adipokine secretion from human adipocytes
in culture. We selected three polyphenols which have been
considered representative, more abundant in human nutri-
tion and more promising in terms of positive eﬀects in
previousstudies[18,19]. Several investigators have evaluated
the role of various ﬂavonoids or resveratrol concerning their
eﬀects on preadipocyte diﬀerentiation, adipogenesis, and
adipocyte apoptosis [20]. We focused on a diﬀerent aspect
of adipocyte metabolism, adipokine secretion. The usual
model selected in previous studies is mouse strain 3T3-L1 or
isolated rat adipocytes. However, in this study, we preferred
to use the human SGBS cell line, because, given the species
diﬀerences in adipose tissue metabolism [21], this cell line
may more closely resemble human adipose tissue.
To the best of our knowledge, this is the ﬁrst report on
the polyphenol-induced modulation of visfatin secretion by
human SGBS adipocytes. Interestingly, measuring visfatin4 Biochemistry Research International
in the lysate yielded minimal amounts, suggesting that the
majority of total visfatin is excreted in the medium, in
accordance with the ﬁndings of Revollo et al. in SGBS ad-
ipocytes [22]. Thus, we presume that polyphenols exert
their eﬀects on visfatin metabolism by modulating both
the production and excretion of this molecule by SGBS
adipocytes. In addition, our results support a substance-
dependent diﬀerential eﬀect of various polyphenols on
visfatin secretion, a ﬁnding that may be related to the
chemical structure of the polyphenols tested. Indeed, we
found that quercetin more potently reduced visfatin secre-
tion compared to resverartol (although these diﬀerences
did not reach statistical signiﬁcance), while the structurally
diﬀerent EGCG did not change visfatin secretion. Similarly,
Chuang et al. [23] have recently demonstrated that quercetin
more eﬃciently improves anti-inﬂammatory pathways and
insulin resistance than resveratrol. Diﬀerential eﬀects of
diﬀerent ﬂavonoids on various aspects of adipose tissue
metabolism have been reported elsewhere as well [24, 25].
Visfatin levels have been found increased in obesity, diabetes
mellitus, hypertension, and cardiovascular disease. Although
the nature of this relationship is still under investigation,
the evidence points towards a proatherogenic role of this
adipokine. In this regard, in vitro visfatin downregulation
by polyphenols might be related to their antiatherogenic
properties.
The eﬀect of polyphenols on leptin metabolism remains
controversial. Thus, Tsuda et al. [26] showed that antho-
cyanin, another ﬂavonoid, induced an increase in leptin
levels in cell medium of isolated rat adipocytes. However,
in our study, none of the polyphenols tested had an eﬀect
on leptin secretion. These diﬀerences can, at least in part,
be attributed to that, by contrast to Tsuda et al., we did
not incubate the cells with an inﬂammatory stimulant, such
as TNF, that may increase baseline leptin levels. To make
things more complicate, studies on rodents fed a diet rich
in polyphenols or injected with EGCG revealed no change
or even a decrease in serum leptin levels [27–30]. Certainly,
comparison between cell cultures and animal studies is not
direct.
We showed no change on adiponectin secretion in the
medium witheithertreatment,a ﬁnding whichsuggeststhat,
at least in mature adipocytes, the polyphenols studied have
no eﬀect. Interestingly, though, anthocyanin was reported to
increase adiponectin gene expression and protein secretion
in cultured rat adipocytes and tissue gene expression exper-
iments [26]. However, apart from using diﬀerent ﬂavonoids
than ours, the concentration used in this study was higher
(4 to 10 fold). Yet, in a recent study by Cho et al. [25],
some ﬂavonoids, including quercetin and EGCG, decreased
adiponectin in mouse 3T3-L1 adipocytes, whereas others
increased it, thus further strengthening the view that various
ﬂavonoids may possess diverse eﬀects and that adipose tissue
metabolism may display important interspecies diﬀerences.
In fact, even within the same model (3T3-L1) and between
in vitro and in vivo studies, results can be contrasting
[28, 31]. In human visceral adipocytes from obese women,
resveratrol increased adiponectin [32]. Maybe, cultured
SGBSadipocytesthatarenottreatedwithaproinﬂammatory
stimulant exhibit a higher basal adiponectin excretion than
(theoretically) more inﬂamed visceral adipocytes that may
counteract inﬂammation after treatment with resveratrol. In
addition, whole body metabolism of an antioxidant mix or
green tea infusion including EGCG may impact indirectly on
adipose tissue and adiponectin, for example, via improved
liver function [33].
In conclusion, from the polyphenols studied, quercetin
and resveratrol decreased visfatin secretion. No eﬀect of the
tested polyphenols on leptin and adiponectin secretion from
human adipocytes in culture was noticed. To the best of our
knowledge, this is the ﬁrst time polyphenols are reported
to modify visfatin secretion from cultured adipocytes. This
ﬁnding might be a potentially beneﬁcial eﬀect of these
compounds on adipose tissue and could contribute to their
antiatherogenic actions. In the future, these polyphenols
might be used pharmacologically for treating obesity-related
metabolic abnormalities. Further research is required to
verify our ﬁndings in cell cultures as well as in animal and
human studies.
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